Literature DB >> 10188974

N-Substituted analogues of S-nitroso-N-acetyl-D,L-penicillamine: chemical stability and prolonged nitric oxide mediated vasodilatation in isolated rat femoral arteries.

I L Megson1, S Morton, I R Greig, F A Mazzei, R A Field, A R Butler, G Caron, A Gasco, R Fruttero, D J Webb.   

Abstract

Previous studies show that linking acetylated glucosamine to S-nitroso-N-acetyl-D,L-penicillamine (SNAP) stabilizes the molecule and causes it to elicit unusually prolonged vasodilator effects in endothelium-denuded, isolated rat femoral arteries. Here we studied the propanoyl (SNPP; 3 carbon side-chain), valeryl (SNVP; 5C) and heptanoyl (SNHP; 7C) N-substituted analogues of SNAP (2C), to further investigate other molecular characteristics that might influence chemical stability and duration of vascular action of S-nitrosothiols. Spectrophotometric analysis revealed that SNVP was the most stable analogue in solution. Decomposition of all four compounds was accelerated by Cu(II) and cysteine, and neocuproine, a specific Cu(I) chelator, slowed decomposition of SNHP. Generation of NO from the compounds was confirmed by electrochemical detection at 37 degrees C. Bolus injections of SNAP (10 microl; 10(-8)-10(-3) M) into the perfusate of precontracted, isolated rat femoral arteries taken from adult male Wistar rats (400-500 g), caused concentration-dependent, transient vasodilatations irrespective of endothelial integrity. Equivalent vasodilatations induced by SNVP and SNHP were transient in endothelium-intact vessels but failed to recover to pre-injection pressures at moderate and high concentrations (10(-6)-10(-3) M) in those denuded of endothelium. This sustained effect (> 1 h) was most prevalent with SNHP and was largely reversed by the NO scavenger, haemoglobin. We suggest that increased lipophilicity of SNAP analogues with longer sidechains facilitates their retention by endothelium-denuded vessels; subsequent slow decomposition within the tissue generates sufficient NO to cause prolonged vasodilatation. This is a potentially useful characteristic for targeting NO delivery to areas of endothelial damage.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10188974      PMCID: PMC1565853          DOI: 10.1038/sj.bjp.0702346

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  37 in total

1.  Comparative evaluation of the predictive power of calculation procedures for molecular lipophilicity.

Authors:  R Mannhold; R F Rekker; C Sonntag; A M ter Laak; K Dross; E E Polymeropoulos
Journal:  J Pharm Sci       Date:  1995-12       Impact factor: 3.534

2.  Effect of Cu2+ on relaxations to the nitrergic neurotransmitter, NO and S-nitrosothiols in the rat gastric fundus.

Authors:  J G De Man; B Y De Winter; G E Boeckxstaens; A G Herman; P A Pelckmans
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

3.  Effect of lipid feeding on endothelium dependent relaxation in rabbit aortic preparations.

Authors:  S P Chappell; M J Lewis; A H Henderson
Journal:  Cardiovasc Res       Date:  1987-01       Impact factor: 10.787

4.  Role of a copper (I)-dependent enzyme in the anti-platelet action of S-nitrosoglutathione.

Authors:  M P Gordge; J S Hothersall; G H Neild; A A Dutra
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 5.  Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP.

Authors:  R A Cohen; P M Vanhoutte
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

6.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta.

Authors:  W Martin; G M Villani; D Jothianandan; R F Furchgott
Journal:  J Pharmacol Exp Ther       Date:  1985-03       Impact factor: 4.030

7.  Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery.

Authors:  R J MacAllister; A L Calver; J Riezebos; J Collier; P Vallance
Journal:  J Pharmacol Exp Ther       Date:  1995-04       Impact factor: 4.030

8.  Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation.

Authors:  A J de Belder; R MacAllister; M W Radomski; S Moncada; P J Vallance
Journal:  Cardiovasc Res       Date:  1994-05       Impact factor: 10.787

9.  Chemical mechanisms underlying the vasodilator and platelet anti-aggregating properties of S-nitroso-N-acetyl-DL-penicillamine and S-nitrosoglutathione.

Authors:  S C Askew; A R Butler; F W Flitney; G D Kemp; I L Megson
Journal:  Bioorg Med Chem       Date:  1995-01       Impact factor: 3.641

10.  Inhibition of platelet activity by S-nitrosoglutathione during coronary angioplasty.

Authors:  E J Langford; A S Brown; R J Wainwright; A J de Belder; M R Thomas; R E Smith; M W Radomski; J F Martin; S Moncada
Journal:  Lancet       Date:  1994-11-26       Impact factor: 79.321

View more
  12 in total

1.  Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.

Authors:  Nadiia Rozmaritsa; Torsten Christ; David R Van Wagoner; Hannelore Haase; Johannes-Peter Stasch; Klaus Matschke; Ursula Ravens
Journal:  Cardiovasc Res       Date:  2013-12-12       Impact factor: 10.787

Review 2.  Recent developments in nitric oxide donor drugs.

Authors:  M R Miller; I L Megson
Journal:  Br J Pharmacol       Date:  2007-04-02       Impact factor: 8.739

3.  A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.

Authors:  Michael S Crane; Adriano G Rossi; Ian L Megson
Journal:  Br J Pharmacol       Date:  2005-03       Impact factor: 8.739

4.  S-nitrosothiols cause prolonged, nitric oxide-mediated relaxation in human saphenous vein and internal mammary artery: therapeutic potential in bypass surgery.

Authors:  N Sogo; C Campanella; D J Webb; I L Megson
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

5.  Antimicrobial nitric oxide releasing surfaces based on S-nitroso-N-acetylpenicillamine impregnated polymers combined with submicron-textured surface topography.

Authors:  Yaqi Wo; Li-Chong Xu; Zi Li; Adam J Matzger; Mark E Meyerhoff; Christopher A Siedlecki
Journal:  Biomater Sci       Date:  2017-06-27       Impact factor: 6.843

6.  Long-term nitric oxide release and elevated temperature stability with S-nitroso-N-acetylpenicillamine (SNAP)-doped Elast-eon E2As polymer.

Authors:  Elizabeth J Brisbois; Hitesh Handa; Terry C Major; Robert H Bartlett; Mark E Meyerhoff
Journal:  Biomaterials       Date:  2013-06-15       Impact factor: 12.479

Review 7.  Recent advances in thromboresistant and antimicrobial polymers for biomedical applications: just say yes to nitric oxide (NO).

Authors:  Yaqi Wo; Elizabeth J Brisbois; Robert H Bartlett; Mark E Meyerhoff
Journal:  Biomater Sci       Date:  2016-05-26       Impact factor: 6.843

8.  The vascular endothelium masks the persistent inhibition of rat thoracic arterial tone induced by S-nitrosoglutathione.

Authors:  M Sarr; F B Sar; L Gueye; M O Kane; A Wele; A S Diallo; V Schini-Kerth; B Muller
Journal:  Cardiovasc J Afr       Date:  2011 Jan-Feb       Impact factor: 1.167

9.  Direct measurement of actual levels of nitric oxide (NO) in cell culture conditions using soluble NO donors.

Authors:  Weilue He; Megan C Frost
Journal:  Redox Biol       Date:  2016-05-16       Impact factor: 11.799

10.  Origin of Long-Term Storage Stability and Nitric Oxide Release Behavior of CarboSil Polymer Doped with S-Nitroso-N-acetyl-D-penicillamine.

Authors:  Yaqi Wo; Zi Li; Elizabeth J Brisbois; Alessandro Colletta; Jianfeng Wu; Terry C Major; Chuanwu Xi; Robert H Bartlett; Adam J Matzger; Mark E Meyerhoff
Journal:  ACS Appl Mater Interfaces       Date:  2015-10-01       Impact factor: 9.229

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.